|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
2.29%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
2.22%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
1.97%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
1.95%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
1.88%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
1.86%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
1.85%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
1.85%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
1.80%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
1.78%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
1.78%
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
1.76%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
1.75%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
1.74%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.74%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
1.73%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
1.73%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
1.71%
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
1.71%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
1.71%
|
US
|
NASDAQ
|